Post-IPO Equity - Alnylam Pharmaceuticals - Mar 28, 2011 Funding Round Profile - Cointime

Bitcoin $99,234.85 +1.33%
Ethereum $3,301.53 -1.71%
BNB $624.17 +0.56%
Optimism $2.13 +0.96%
Arbitrum $0.78 -0.69%
Solana $254.52 -0.97%
Polygon $0.48 +5.56%
Cosmos $7.32 +15.74%
Avalanche $39.73 +10.93%

Bitcoin $99,234.85 +1.33%
Ethereum $3,301.53 -1.71%
BNB $624.17 +0.56%
Optimism $2.13 +0.96%
Arbitrum $0.78 -0.69%
Solana $254.52 -0.97%
Polygon $0.48 +5.56%
Cosmos $7.32 +15.74%
Avalanche $39.73 +10.93%

Alnylam Pharmaceuticals

company

Funding Round

Post-IPO Equity

Money Raised

$ 10M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion
Takeda	-	Yes	-	Detail

Historical Financing

Announced Date	Round	Money Raised	Investors
Jul 7, 2003	Private Equity（PE）	$ 24.60M	Merck,ARCH Venture Partners	Detail